Jennifer Cruickshank

Toronto, ON M5G2C4, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.

Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.

Journal: International journal of molecular sciences
Published: February 08, 2026

A Biomimetic Buffering Hydrogel Scaffold for Long-Term Culture of Patient-Derived Tumor Organoids.

A Biomimetic Buffering Hydrogel Scaffold for Long-Term Culture of Patient-Derived Tumor Organoids.

Journal: Advanced healthcare materials
Published: September 22, 2025

Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays.

Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays.

Journal: Science advances
Published: July 30, 2025

Microfluidic Platform for Generating and Releasing Patient-Derived Cancer Organoids with Diverse Shapes: Insight into Shape-Dependent Tumor Growth.

Microfluidic Platform for Generating and Releasing Patient-Derived Cancer Organoids with Diverse Shapes: Insight into Shape-Dependent Tumor Growth.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: July 20, 2024

Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality.

Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality.

Journal: Cancer research
Published: September 19, 2022

The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations.

The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations.

Journal: Science advances
Published: September 07, 2022

Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells.

Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells.

Journal: Journal of proteome research
Published: August 18, 2022

PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.

PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.

Journal: Nature chemical biology
Published: June 22, 2021

Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies.

Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies.

Journal: Advanced healthcare materials
Published: June 03, 2021

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.

Journal: Nature communications
Published: February 02, 2021

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer.

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: December 26, 2020

Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.

Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.

Journal: Nature communications
Published: August 31, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026